| HGNC Family | G protein-coupled receptors |
| Name | atypical chemokine receptor 3 |
| Description | This gene encodes a member of the G-protein coupled receptor family. Although this protein was earlier thought to be a receptor for vasoactive intestinal peptide (VIP), it is now considered to be an orphan receptor, in that its endogenous ligand has not been identified. The protein is also a coreceptor for human immunodeficiency viruses (HIV). Translocations involving this gene and HMGA2 on chromosome 12 have been observed in lipomas. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n ACKR3 (also known as CXCR7 or RDC1) is an atypical chemokine receptor that binds with high affinity to CXCL12 and CXCL11. Unlike classical G‐protein–coupled receptors that mediate rapid Ca²⁺ mobilization and chemotaxis, ACKR3 often acts as a “scavenger” receptor capable of internalizing and degrading its ligands, thereby modulating local chemokine gradients and indirectly regulating CXCR4‐dependent responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In developmental contexts, ACKR3 plays critical roles in cardiac, neuronal, and vascular formation. It is expressed on a variety of cells—including activated endothelial cells, fetal liver cells, and migrating cortical interneurons—and contributes to processes such as interneuron migration and laminar positioning in the brain."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "8"}]}, {"type": "t", "text": " Moreover, ACKR3 contributes to cardiovascular development, as evidenced by defects in CXCR7‐deficient mice that include myocardial degeneration and fibrosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In the context of cancer, ACKR3 is emerging as a key regulator of tumor progression. It is expressed by various tumor cell types—including breast, lung, astroglial, hepatocellular, and esophageal cancers—and promotes tumor cell survival, adhesion, and growth. In many models, ACKR3 enhances angiogenesis and is associated with resistance to drug‐induced apoptosis, increased metastasis, and poorer clinical outcomes. In addition, when co‐expressed with CXCR4, ACKR3 modulates the balance of intracellular signaling by preferentially recruiting β‐arrestin and attenuating canonical G₍i₎–mediated pathways, thereby affecting directional migration and chemotactic responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "17"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n ACKR3 also influences the tumor microenvironment by regulating transendothelial migration of cancer cells, modulating integrin rearrangement, and affecting the recruitment of pro‐tumorigenic immune cells. Its expression is upregulated by inflammatory stimuli and hypoxia and can be induced downstream of cytokine signaling (for example via IL‑6 in esophageal cancer), linking the receptor to chemoresistance and aggressive disease phenotypes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "23"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Interestingly, despite its inability to trigger classical chemotactic signaling, ACKR3 actively engages intracellular pathways by recruiting adapter proteins such as β‐arrestin and, in some cell types (e.g., astrocytes), by activating pertussis toxin–sensitive G(i/o) proteins. This ligand‑biased signaling demonstrates that ACKR3 not only modulates chemokine availability but also transduces distinct intracellular signals that can influence processes ranging from cell migration to survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its roles in development and cancer, ACKR3 functions are also implicated in regulating immune cell behavior. For instance, in rheumatoid arthritis, altered promoter methylation of CXCL12 combined with activation via CXCR7 on synovial fibroblasts contributes to enhanced expression of matrix metalloproteinases and joint destruction."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": " In addition, in breast cancer, differential regulation of ACKR3 (versus CXCR4) by estrogens affects cell growth and tumorigenesis, and its expression correlates with markers of tumor aggressiveness and poor prognosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}, {"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, ACKR3 is a multifunctional receptor that integrates chemokine scavenging with active, often β‑arrestin– and G(i/o)–mediated signaling pathways. Through these mechanisms, it plays diverse roles in development, modulation of immune responses, and the progression of cancers, making it an attractive therapeutic target in a range of pathological conditions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "10"}, {"type": "fg_f", "ref": "3"}, {"type": "fg_fs", "start_ref": "11", "end_ref": "13"}, {"type": "fg_f", "ref": "6"}, {"type": "fg_f", "ref": "18"}, {"type": "fg_f", "ref": "4"}, {"type": "fg_f", "ref": "7"}, {"type": "fg_f", "ref": "20"}, {"type": "fg_f", "ref": "9"}, {"type": "fg_f", "ref": "14"}, {"type": "fg_f", "ref": "5"}, {"type": "fg_f", "ref": "24"}, {"type": "fg_f", "ref": "8"}, {"type": "fg_f", "ref": "25"}, {"type": "fg_fs", "start_ref": "15", "end_ref": "17"}, {"type": "fg_f", "ref": "21"}, {"type": "fg_f", "ref": "26"}, {"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jennifer M Burns, Bretton C Summers, Yu Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20052144"}], "href": "https://doi.org/10.1084/jem.20052144"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16940167"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16940167"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Karl Balabanian, Bernard Lagane, Simona Infantino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M508234200"}], "href": "https://doi.org/10.1074/jbc.M508234200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16107333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16107333"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Ulrike Naumann, Elisabetta Cameroni, Monika Pruenster, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR7 functions as a scavenger for CXCL12 and CXCL11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0009175"}], "href": "https://doi.org/10.1371/journal.pone.0009175"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20161793"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20161793"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "K E Luker, S A Lewin, L A Mihalko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.633"}], "href": "https://doi.org/10.1038/onc.2011.633"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22266857"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22266857"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Paul Proost, Anneleen Mortier, Tamara Loos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2006-10-049072"}], "href": "https://doi.org/10.1182/blood-2006-10-049072"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17363734"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17363734"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yanling Wang, Guangnan Li, Amelia Stanco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR4 and CXCR7 have distinct functions in regulating interneuron migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuron (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuron.2010.12.005"}], "href": "https://doi.org/10.1016/j.neuron.2010.12.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21220099"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21220099"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Gabriel L McKinsey, Susan Lindtner, Brett Trzcinski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dlx1&2-dependent expression of Zfhx1b (Sip1, Zeb2) regulates the fate switch between cortical and striatal interneurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuron (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuron.2012.11.035"}], "href": "https://doi.org/10.1016/j.neuron.2012.11.035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23312518"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23312518"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Daniel Vogt, Robert F Hunt, Shyamali Mandal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lhx6 directly regulates Arx and CXCR7 to determine cortical interneuron fate and laminar position."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuron (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuron.2014.02.030"}], "href": "https://doi.org/10.1016/j.neuron.2014.02.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24742460"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24742460"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Han Gerrits, Dorette S van Ingen Schenau, Nicole E C Bakker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genesis (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dvg.20387"}], "href": "https://doi.org/10.1002/dvg.20387"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18442043"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18442043"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Zhenhua Miao, Kathryn E Luker, Bretton C Summers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0610444104"}], "href": "https://doi.org/10.1073/pnas.0610444104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17898181"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17898181"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Fabien M Décaillot, Manija A Kazmi, Ying Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.277038"}], "href": "https://doi.org/10.1074/jbc.M111.277038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21730065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21730065"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Brian A Zabel, Yu Wang, Susanna Lewén, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0900269"}], "href": "https://doi.org/10.4049/jimmunol.0900269"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19641136"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19641136"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Kirsten Hattermann, Janka Held-Feindt, Ralph Lucius, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-09-3642"}], "href": "https://doi.org/10.1158/0008-5472.CAN-09-3642"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20388803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20388803"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Lorena Hernandez, Marco A O Magalhaes, Salvatore J Coniglio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/bcr3074"}], "href": "https://doi.org/10.1186/bcr3074"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22152016"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22152016"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Nissar Wani, Mohd W Nasser, Dinesh K Ahirwar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/bcr3665"}], "href": "https://doi.org/10.1186/bcr3665"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24886617"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24886617"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Kathryn E Luker, Mudit Gupta, Jessica M Steele, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Imaging ligand-dependent activation of CXCR7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.09724"}], "href": "https://doi.org/10.1593/neo.09724"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19794961"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19794961"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Antoine Boudot, Gwenneg Kerdivel, Denis Habauzit, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0020898"}], "href": "https://doi.org/10.1371/journal.pone.0020898"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21695171"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21695171"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Tanja Nicole Hartmann, Valentin Grabovsky, Ronit Pasvolsky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.0208088"}], "href": "https://doi.org/10.1189/jlb.0208088"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18653785"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18653785"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Lillian Cruz-Orengo, David W Holman, Denise Dorsey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20102010"}], "href": "https://doi.org/10.1084/jem.20102010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21300915"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21300915"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Y Qiao, C Zhang, A Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2017.387"}], "href": "https://doi.org/10.1038/onc.2017.387"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29059160"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29059160"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Shotaro Iwakiri, Nobuya Mino, Tsuyoshi Takahashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cncr.24281"}], "href": "https://doi.org/10.1002/cncr.24281"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19309748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19309748"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Shangze Li, Ka-Wing Fong, Galina Gritsina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-18-2812"}], "href": "https://doi.org/10.1158/0008-5472.CAN-18-2812"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30952632"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30952632"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Evemie Schutyser, Yingjun Su, Yingchun Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Cytokine Netw (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1684/ecn.2007.0087"}], "href": "https://doi.org/10.1684/ecn.2007.0087"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17594938"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17594938"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Veysel Odemis, Jana Lipfert, Robert Kraft, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glia (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/glia.22271"}], "href": "https://doi.org/10.1002/glia.22271"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22083878"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22083878"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "E Karouzakis, Y Rengel, A Jüngel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Immun (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/gene.2011.45"}], "href": "https://doi.org/10.1038/gene.2011.45"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21753787"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21753787"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Rebecca Winkelmann, Lena Sandrock, Martina Porstner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "B cell homeostasis and plasma cell homing controlled by Krüppel-like factor 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1012858108"}], "href": "https://doi.org/10.1073/pnas.1012858108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21187409"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21187409"}]}]}]}
|
| Synonyms | GPR159, CMKOR1, CXCR-7, CXC-R7, CXCR7 |
| Proteins | ACKR3_HUMAN |
| NCBI Gene ID | 57007 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ACKR3 has 14,266 functional associations with biological entities spanning 8 categories (molecular profile, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 114 datasets.
Click the + buttons to view associations for ACKR3 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of ACKR3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of ACKR3 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ACKR3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of ACKR3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of ACKR3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of ACKR3 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of ACKR3 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of ACKR3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of ACKR3 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of ACKR3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of ACKR3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of ACKR3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with ACKR3 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with ACKR3 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ACKR3 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of ACKR3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of ACKR3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of ACKR3 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing ACKR3 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of ACKR3 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing ACKR3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing ACKR3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with ACKR3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with ACKR3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with ACKR3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with ACKR3 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with ACKR3 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by ACKR3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for ACKR3 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with ACKR3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with ACKR3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with ACKR3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with ACKR3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with ACKR3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with ACKR3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ACKR3 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ACKR3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of ACKR3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing ACKR3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with ACKR3 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of ACKR3 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with ACKR3 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing ACKR3 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of ACKR3 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of ACKR3 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of ACKR3 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving ACKR3 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving ACKR3 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving ACKR3 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing ACKR3 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing ACKR3 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing ACKR3 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by ACKR3 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by ACKR3 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by ACKR3 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of ACKR3 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of ACKR3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of ACKR3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ACKR3 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of ACKR3 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding ACKR3 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| Guide to Pharmacology Protein Ligands of Receptors | ligands (protein) binding ACKR3 receptor from the curated Guide to Pharmacology Protein Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with ACKR3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with ACKR3 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with ACKR3 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of ACKR3 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of ACKR3 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of ACKR3 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ACKR3 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for ACKR3 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with ACKR3 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with ACKR3 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by ACKR3 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for ACKR3 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of ACKR3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of ACKR3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of ACKR3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving ACKR3 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of ACKR3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with ACKR3 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of ACKR3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of ACKR3 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of ACKR3 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain ACKR3 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by ACKR3 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting ACKR3 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by ACKR3 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of ACKR3 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of ACKR3 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of ACKR3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of ACKR3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving ACKR3 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving ACKR3 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving ACKR3 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving ACKR3 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of ACKR3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ACKR3 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of ACKR3 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of ACKR3 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of ACKR3 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with ACKR3 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of ACKR3 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of ACKR3 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of ACKR3 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of ACKR3 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of ACKR3 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of ACKR3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ACKR3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of ACKR3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ACKR3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with ACKR3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with ACKR3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving ACKR3 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving ACKR3 protein from the WikiPathways Pathways 2024 dataset. | |